Data as of Mar 14
| -0.47 / -1.76%|
The 3 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 32.00, with a high estimate of 55.00 and a low estimate of 28.00. The median estimate represents a +21.90% increase from the last price of 26.25.
The current consensus among 3 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.